CClinicalTrials.gg
CompletedNCT04842097Updated Sep 22, 2022

Online Mindfulness-based Stress Reduction Intervention for People With Chronic Pain Waiting for Health Services

An interventional study of Mindfulness-based stress reduction in Chronic Pain, sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal. Completed at 3 sites in Canada. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2022-09-22.

Sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The goal of this project is to explore the feasibility and the efficacy of a online mindfulness-based stress reduction intervention for people with chronic pain waiting for secondary or tertiary health care services

02

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • mindfulness-based stress reduction intervention
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal is the lead sponsor of 17 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men and women aged 18-85
  • Self-reported diagnosis of chronic non-cancer pain
  • Chronic non-cancer pain duration of 3 months or more
  • Chronic non-cancer pain experienced during 4 days or more per week
  • Average pain intensity of 4 or more out of 10 in the last seven days
  • French or English fluency
  • Access to Wi-Fi
  • Be able to attend a weekly two-hour MBSR virtual session for eight consecutive weeks

Exclusion criteria

Exclusion Criteria:

  • Cancer-related chronic pain
  • Currently receiving or have received in the last 24 months coordinated care in pain clinics, hospitals or rehabilitation centers.
  • Current or recent participation (in the last 12 months and more than 12 sessions) of cognitive-behavioral therapy or MBSR program
  • Having an unstable psychological conditions such as depression, bipolar disorder, post-traumatic stress disorder, psychotic disorder
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Mindfulness-based stress reduction intervention

    Online 8-week group program, once per week

    Behavioral: Mindfulness-based stress reduction

  • No intervention
    Waiting list

    Controls will not receive any intervention during this time. They are on chronic pain clinics waiting list

Interventions

  • BehavioralMindfulness-based stress reduction

    An online mindfulness-based stress reduction intervention will be administered in a group format of maximum 15 participants, once a week for 120 minutes for 8 weeks by an experienced therapist trained in MBSR. Sessions will include sitting and lying meditation, hatha yoga and a body scan where attention is sequentially focused on different parts of the body. Individual autonomous practice between 30-45 minutes, 6 times / week will also be recommended. To support individual autonomous practice, a daily diary and two guided videos (around 35 minutes/each) were created.

06

What researchers measure

Primary outcomes

  1. Participants retention rate

    The percentage of participants who have completed the 8 online MBSR sessions

    Time frame: 2 months

  2. Participants participation rate

    The percentage of participants on waiting lists who agreed to participate in the intervention

    Time frame: 12 months

Secondary outcomes

  1. Patient-Reported Outcomes Measurement Information System Global-10

    Change in domains of health and functioning as measured by the PROMIS Global-10, score range is 7-35 with increases in scores meaning better outcome

    Time frame: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)

  2. Patient-Reported Outcomes Measurement Information System 29

    Change in 8 health-related quality of life domains as measured by the PROMIS 29. PROMIS-29 is a generic patient reported outcome measure, which includes four items from each of the seven PROMIS domains (physical function, depression, anxiety, fatigue, sleep disturbance, and ability to participate in social roles and activities, pain interference) and a single item on pain intensity. Each item has five response options (values 1 to 5), except for the pain intensity item which has eleven response options (values 0 to 10). A total raw score is computed for each domain as the sum of the response to each question within the domain, leading to seven domain scores, each from 4 to 20.

    Time frame: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)

  3. French-Canadian Chronic Pain Self-Efficacy Scale

    The French-Canadian Chronic Pain Self-Efficacy Scale (Lacasse et al., 2015) is a 6-item scale that measures an individual's confidence in his/her ability to manage chronic pain in general and pain-related symptoms. Items are rated on a 10-point Likert scale ranging from 1 = not at all confident to 10 = entirely confident. Score range is 6-60 with higher scores reflecting greater chronic pain self-efficacy.

    Time frame: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)

  4. Chronic Pain Acceptance Questionnaire

    The Chronic Pain Acceptance Questionnaire (CPAQ-8; Fish et al., 2010 ) is an 8-item scale comprised of two subscales: activity engagement and pain willingness. Items are scored on a 7-point Likert scale ranging from 0 = never true to 6 = always true. Score range is 0-48 with increases in scores meaning better outcome.

    Time frame: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)

  5. Global Rating of Change Scale

    The Global Change Rating Scale (11-point visual analogue scale raging from minus 5 to plus 5) will be used to assess the participants' perception of improvement (or decline) in relation to their self-efficacy in manging pain at the end of the MBSR intervention.

    Time frame: 3-month follow-up (week 21)

  6. Pain Catastrophizing Scale

    Change in pain catastrophizing as measured by the Pain Catastrophizing Scale (French Canadian version). PCS is a 13-item measure using a 5-point Likert scale (0=not at all, 4=all the time) with score range between 0-52 with decreases in scores meaning better outcome.

    Time frame: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)

  7. Pain Disability Index

    Change in pain disability as measured by the The French-Canadian Pain Disability Index (score range is 0-70 with decreases in scores meaning better outcome)

    Time frame: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)

07

Study locations

3 sites
  • Association québécoise de la douleur chronique
    Montreal, Quebec H1V2C8, Canada
  • Centre de réadaptation Layton-Lethbridge-Mackay
    Montreal, Quebec H4B 1T3, Canada
  • Hôpital de Verdun
    Montreal, Quebec H4G 2A3, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04842097
Lead sponsor
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal
Responsible party
Diana Zidarov (site researcher, Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal) — Principal investigator
First posted
Apr 13, 2021
Start date
Jun 16, 2021
Primary completion
Dec 20, 2021
Completion
Jan 24, 2022
Last update
Sep 22, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion